Company / Gross Profit
Innoviva, Inc. Gross Profit History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$307.7M
FY2025
5-year range
$246.0M / $307.7M
FY2023-FY2025
Trend
+3.9%
vs FY2024
Sector context
#18 of 29
Health Care
What the data says
At $308M, Innoviva, Inc.'s gross profit ranks #18 of 29 in the Health Care sector. Improved from $246M to $308M over the past 2 years.
Based on SEC 10-K filings.
$308M in FY2025.
Improved from $246M to $308M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#18 of 29 in Health CareTop 62% of 29This company $307.7M Sector average $3.5B
▼
-91.1% below sector average
Key checks
Key Insights
- In FY2025, gross profit increased 3.9% year-over-year.
- Ranks #18 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $307.7M | +3.9% |
| FY2024 | $296.2M | +20.4% |
| FY2023 | $246.0M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026